Il y a eu 50 transactions d'initiés récentes enregistrées pour Emmaus Life Sciences, Inc. (EMMA), dont 46 achats et 3 ventes. Le total des achats d'initiés s'élève à $44.65M et le total des ventes d'initiés à $1.07M.
Les initiés notables ayant une activité récente comprennent Kuwahara Jon, Lim Seah H., Lee Willis C. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — EMMA
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-10-01 |
Kuwahara Jon |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-09-16 |
Lim Seah H. |
Director |
Achat Informatif |
20,000 |
$0.04 |
$800.00 |
4,606,626 |
| 2024-02-29 |
Lee Willis C |
Co-president & COO |
Achat Informatif |
77,000 |
$0.13 |
$10.01K |
159,400 |
| 2024-02-28 |
Lee Willis C |
Co-president & COO |
Achat Informatif |
15,000 |
$0.12 |
$1.8K |
82,400 |
| 2024-02-27 |
Lee Willis C |
Co-president & COO |
Achat Informatif |
10,000 |
$0.13 |
$1.3K |
67,400 |
| 2024-02-26 |
Lee Willis C |
Co-president & COO |
Achat Informatif |
13,200 |
$0.12 |
$1.58K |
57,400 |
| 2024-02-01 |
Lee Willis C |
Co-president & COO |
Attribution de RSU |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Nagasaki Yasushi |
CFO |
Attribution de RSU |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Zwicker Ian Harvey |
Director |
Attribution de RSU |
100,000 |
$0.15 |
$15K |
100,000 |
| 2024-02-01 |
Zen Wei Peu |
Director |
Attribution de RSU |
100,000 |
$0.15 |
$15K |
100,000 |
| 2024-02-01 |
Sekulich George |
Co-president & Cco |
Attribution de RSU |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Stark Charles William |
CSO & EVP Clinical Development |
Attribution de RSU |
200,000 |
$0.15 |
$30K |
200,000 |
| 2024-02-01 |
Lim Seah H. |
Director |
Attribution de RSU |
100,000 |
$0.15 |
$15K |
100,000 |
| 2023-12-20 |
Lim Seah H. |
Director |
Vente Informative |
32,500 |
$0.05 |
$1.63K |
4,586,626 |
| 2023-12-15 |
Zen Wei Peu |
Director |
Autre (Achat) |
3,760,983 |
$0.29 |
$1.09M |
4,768,817 |
| 2023-12-15 |
Lim Seah H. |
Director |
Autre (Vente) |
240,000 |
$0.29 |
$69.6K |
- |
| 2023-11-30 |
Lee Willis C |
COO |
Achat Informatif |
59,400 |
$0.12 |
$7.13K |
395,124 |
| 2023-11-30 |
Lee Willis C |
COO |
Achat Informatif |
7,417 |
$0.12 |
$890.04 |
395,124 |
| 2023-11-29 |
Lee Willis C |
COO |
Achat Informatif |
36,000 |
$0.12 |
$4.32K |
335,724 |
| 2023-11-29 |
Lee Willis C |
COO |
Achat Informatif |
4,325 |
$0.12 |
$519.00 |
335,724 |
| 2023-11-28 |
Lee Willis C |
COO |
Achat Informatif |
12,000 |
$0.12 |
$1.44K |
299,724 |
| 2023-11-28 |
Lee Willis C |
COO |
Achat Informatif |
1,470 |
$0.12 |
$176.40 |
299,724 |
| 2023-11-14 |
Lee Willis C |
COO |
Achat Informatif |
1,100 |
$0.12 |
$132.00 |
44,200 |
| 2023-11-14 |
Lee Willis C |
COO |
Achat Informatif |
132 |
$0.12 |
$15.84 |
44,200 |
| 2023-09-05 |
Lim Seah H. |
Director |
Achat Informatif |
1,700 |
$0.15 |
$255.00 |
177,700 |
| 2023-08-31 |
Lee Willis C |
COO |
Achat Informatif |
6,000 |
$0.15 |
$900.00 |
43,100 |
| 2023-08-31 |
Lee Willis C |
COO |
Achat Informatif |
900 |
$0.15 |
$135.00 |
43,100 |
| 2023-08-30 |
Lim Seah H. |
Director |
Achat Informatif |
20,000 |
$0.15 |
$3K |
176,000 |
| 2023-08-25 |
Lee Willis C |
COO |
Achat Informatif |
6,500 |
$0.21 |
$1.37K |
37,100 |
| 2023-08-25 |
Lee Willis C |
COO |
Achat Informatif |
1,365 |
$0.21 |
$286.65 |
37,100 |
| 2023-08-25 |
Lim Seah H. |
Director |
Achat Informatif |
92,100 |
$0.27 |
$24.87K |
156,000 |
| 2023-05-31 |
Lee Willis C |
COO |
Achat Informatif |
28,700 |
$0.29 |
$8.32K |
30,600 |
| 2023-01-18 |
Zen Wei Peu |
Director |
Achat Informatif |
2,000,000 |
$0.50 |
$1M |
2,000,000 |
| 2023-01-18 |
Zen Wei Peu |
Director |
Autre (Vente) |
2,000,000 |
$0.50 |
$1M |
- |
| 2023-01-12 |
Niihara Yutaka |
Chairman and CEO |
Attribution de RSU |
7,500,000 |
$4.50 |
$33.75M |
- |
| 2023-01-12 |
Lee Willis C |
COO |
Attribution de RSU |
750,000 |
$4.50 |
$3.38M |
750,000 |
| 2023-01-12 |
Nagasaki Yasushi |
CFO |
Attribution de RSU |
150,000 |
$4.50 |
$675K |
150,000 |
| 2023-01-12 |
Zwicker Ian Harvey |
Director |
Attribution de RSU |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Zen Wei Peu |
Director |
Attribution de RSU |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Sekulich George |
CIO & SVP |
Attribution de RSU |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Stark Charles William |
SVP, Clinical Development |
Attribution de RSU |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Lim Seah H. |
Director |
Attribution de RSU |
100,000 |
$4.50 |
$450K |
100,000 |
| 2023-01-12 |
Lee Willis C |
COO |
Attribution de RSU |
500,000 |
$4.50 |
$2.25M |
500,000 |
| 2022-11-30 |
Niihara Yutaka |
Chairman and CEO |
Achat Informatif |
22,900 |
$0.41 |
$9.39K |
12,040,857 |
| 2022-11-29 |
Niihara Yutaka |
Chairman and CEO |
Achat Informatif |
14,700 |
$0.38 |
$5.59K |
12,017,957 |
| 2022-11-28 |
Niihara Yutaka |
Chairman and CEO |
Achat Informatif |
5,000 |
$0.35 |
$1.75K |
12,003,257 |
| 2022-11-04 |
Niihara Yutaka |
Chairman and CEO |
Achat Informatif |
7,500 |
$0.45 |
$3.38K |
11,998,257 |
| 2022-11-03 |
Niihara Yutaka |
Chairman and CEO |
Achat Informatif |
2,500 |
$0.45 |
$1.13K |
11,990,757 |
| 2022-11-02 |
Niihara Yutaka |
Chairman and CEO |
Achat Informatif |
15,000 |
$0.43 |
$6.45K |
11,988,257 |
| 2022-11-01 |
Niihara Yutaka |
Chairman and CEO |
Achat Informatif |
5,000 |
$0.43 |
$2.15K |
11,973,257 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
